RN

Rajesh Negi

Active Director Director DIN 10169092
DIN 10169092 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Rajesh Negi

Data last updated:

Rajesh Negi is a Director at Risingsol Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Risingsol Pharmaceuticals Private Limited reported revenue of ₹18 Lakh (FY 2024).

DIN 10169092
Primary Designation Director
Industry Pharma
First Appointment 18 May 2023
Oldest Company Age 3 yrs
Largest company Risingsol Pharmaceuticals Private Limited · ₹18 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 May 20232023₹18 Lakh (FY 2024)Active

Board colleagues of Rajesh Negi

NameDINCompanyDesignation
Prakash Ram10169093Risingsol Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Risingsol Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Negi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Negi

Rajesh Negi currently holds 1 directorship: Risingsol Pharmaceuticals Private Limited (Director, since 18 May 2023, revenue ₹18 Lakh (FY 2024)).

Rajesh Negi was first appointed on 18 May 2023 as Director at Risingsol Pharmaceuticals Private Limited.

The current boards of Rajesh Negi's companies include Prakash Ram (Risingsol Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available